Global Medical Alpha Radionuclide Market to Reach USD 12.85 Billion by 2034, Growing at a 14.9% CAGR
Global Medical Alpha Radionuclide market was valued at USD 3.64 billion in 2025 and is projected to reach USD 12.85 billion by 2034, registering a CAGR of 14.9% during the forecast period. Growth is driven by rising adoption of targeted alpha therapies, increasing cancer prevalence, and advancements in radiopharmaceutical research.
Full Report Link: https://www.24chemicalresearch.....com/reports/285134/
Like
Comment
Share
